AAAAAA

   
Results: 1-5 |
Results: 5

Authors: MEHTA J KELSEY S CHU P POWLES R HAZEL D RILEY U EVANS C NEWLAND A TRELEAVEN J SINGHAL S
Citation: J. Mehta et al., AMPHOTERICIN-B LIPID COMPLEX (ABLC) FOR THE TREATMENT OF CONFIRMED ORPRESUMED FUNGAL-INFECTIONS IN IMMUNOCOMPROMISED PATIENTS WITH HEMATOLOGIC MALIGNANCIES, Bone marrow transplantation, 20(1), 1997, pp. 39-43

Authors: SOMASUNDRAM U HAZEL D NEWLAND AC HUGHES A BOOTS M WATTS E MCMILLAN AK JANMOHAMMED R JOHNSON S SAMSON D
Citation: U. Somasundram et al., ORAL IDARUBICIN AND GM-CSF FOR THE TREATMENT OF MYELODYSPLASTIC SYNDROMES (MDS), British Journal of Haematology, 93, 1996, pp. 77-77

Authors: KELSEY SM HAZEL D MURRELL C NEWLAND AC
Citation: Sm. Kelsey et al., GM-CSF FOR PERIPHERAL-BLOOD STEM-CELL HARVEST IN MYELOMA, British Journal of Haematology, 92(2), 1996, pp. 505-505

Authors: MEHTA J KELSEY SM CHU P POWLES R SINGHAL S HAZEL D NEWLAND AC TRELEAVEN J
Citation: J. Mehta et al., COMPLEX (ABLC) FOR FUNGAL SEPSIS IN IMMUNOCOMPROMISED ADULTS, Blood, 88(10), 1996, pp. 3782-3782

Authors: MEHTA J KELSEY SM CHU P POWLES R SINGHAL S HAZEL D NEWLAND AC TRELEAVEN J
Citation: J. Mehta et al., AMPHOTERICIN-B LIPID COMPLEX (ABLC) FOR FUNGAL SEPSIS IN IMMUNOCOMPROMISED PATIENTS, Blood, 86(10), 1995, pp. 2042-2042
Risultati: 1-5 |